Articles

Resolving Truncated Impurities in Single Guide RNA Purity Analysis

Analytical quality by design (AQbD) helped refine an ion-pair reversed-phase LC method for separating sgRNA from closely related impurities.
Written byAimee Cichocki
Presented byLara Nercessian
Model of sgRNA analysis in a laboratory setting

Google Flow 2026

Register for free to listen to this article
Listen with Speechify
0:00
3:00

An RNA strand one nucleotide shorter than the intended product presents a demanding separation problem. In single-guide RNA (sgRNA) purity analysis, resolving that n−1 impurity can determine how well the analytical method distinguishes the main product from closely related impurities.

In a recent Phenomenex symposium, Lara Nercessian, M.S., R&D Analytical Scientist at Quality Assistance, presented the development of an ion-pair reversed-phase liquid chromatography (IP-RP LC) method to address that challenge. The work combined initial screening, risk assessment, and a design of experiments to find conditions that resolved truncated species while keeping the main sgRNA peak together.

The approach began with a change in emphasis. Nercessian explains that analytical quality by design shifts the focus from testing to understanding. “That means understanding why the method behaves the way it does and which parameters really matter.”

Defining What the Method Must Measure

Nercessian describes sgRNA as an RNA molecule of around 100 nucleotides that guides the Cas9 enzyme to a genomic target. Its length, chemical modifications, and closely related synthesis impurities complicate purity analysis. Shorter and longer species can accompany the intended product, creating a separation challenge before analysts can assign a purity value.

Working in analytical science?

Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.

Subscribe for free

The team first defined an analytical target profile: the method should measure sgRNA purity with precision of no more than 2% and bias of no more than 5%, detect meaningful changes in purity, and target a limit of quantitation of 0.2%. These figures defined the intended performance; they did not represent completed validation results.

“At this stage, no specific analytical method is imposed,” Nercessian notes. The target profile established what the analysis needed to achieve before the team selected IP-RP LC and a Phenomenex C18 column.

Balancing Impurity Resolution and Main Peak Splitting

Initial experiments varied one factor at a time to compare ion-pairing reagents and organic solvents. Triethylammonium acetate with acetonitrile offered the best compromise between resolution and sensitivity among the conditions tested.

Increasing the ion-pairing reagent concentration reduced resolution for some impurities. At the higher concentration, the main peak also began to split, which Nercessian suggests could reflect separation of diastereoisomers. Small pH changes within the tested range had little effect on the separation.

These observations exposed an important trade-off. The method needed to distinguish impurities from the intended sgRNA, but the team also wanted to avoid resolving diastereoisomers within the main product peak.

“This step was not intended to fully optimize the method, but to generate the scientific knowledge required for the following risk assessment,” Nercessian emphasizes.

Finding the Parameters That Influence Separation

The team mapped potential sources of variability and ranked their risks. Four continuous parameters emerged for further investigation: column temperature, flow rate, gradient slope, and the duration of the initial isocratic hold. Sample stability and column batch also warranted separate evaluation.

A central composite design then examined the four continuous parameters across 26 experimental runs. This allowed the team to investigate interactions and curved responses that the initial one-factor-at-a-time screening could not capture.

The resulting chromatograms showed substantial differences. Some conditions resolved the impurity profile; others lost resolution or split the main peak. Nercessian observes that visual inspection alone is not sufficient.

Continue reading below…
WebinarsSample vials in line waiting for analysis inside injection port.
From Downtime to Data: How Long-Life LC Columns Transform High-Throughput Labs
Discover practical strategies for maximizing LC column lifetime, and improving performance in high-throughput, complex matrix workflows.
Read More

Without known impurity reference standards at this stage, the team used three practical measures to guide optimization: total peak count, the number of peaks within the main peak, and total area corrected for flow rate. These served as indicators of resolving power, unwanted main-peak splitting, and response or recovery, respectively.

The optimization therefore sought more resolved peaks overall, one main product peak, and a high corrected total area. The selected conditions included a flow rate of 0.35 mL/min, a column temperature of 45 °C, UV detection at 260 nm, and a total run time of 33 minutes.

Challenging the Method With Truncated RNA

Triplicate injections under the optimized conditions produced overlapping chromatograms and a relative standard deviation below 1% for total area. The team then assessed resolving power by spiking an sgRNA sample with n−5, n−2, and n−1 species.

The experiments demonstrated separation of all three truncated species from the main sgRNA peak. The n−1 result carried particular significance. “Separation from the n−1 impurity is often the most critical point in purity determination,” Nercessian explains.

An in-process sample provided a further challenge. It contained a relatively high impurity level, and the analysis returned a purity value of approximately 70%. Nercessian stresses that the sample was intentionally selected for this case study. It represented material used to challenge the method, rather than the purity expected of a final drug substance.

Building Toward a Broader Method

The case study established repeatable conditions and demonstrated resolving power for selected truncated impurities. Further work remained: robustness studies, definition of a method operable design region, and method qualification. Nercessian also identifies testing other sgRNA sequences as a route toward a platform method.

For analysts developing sgRNA purity methods, the study illustrates how an explicit measurement objective can guide decisions throughout development. Initial screening revealed useful trends, risk assessment narrowed the experimental focus, and multivariate optimization balanced impurity separation against main-peak splitting. Spiking experiments ultimately demonstrated that those development decisions enabled separation of the closely related truncated species most critical to accurate sgRNA purity determination.

Add Separation Science as a preferred source on Google

Add Separation Science as a preferred Google source to see more of our trusted coverage

Meet the Author(s):

  • Aimee Cichocki is the Editorial Director at Separation Science and Chromatography Forum. Aimee brings a broad range of experience in creating, editing, and formatting scientific content. With a degree in medicinal chemistry, a 10-year background in formulation chemistry, an MBA, and a diverse background in publishing, Aimee guides editorial initiatives at Separation Science and Chromatography Forum. Aimee is dedicated to ensuring the delivery of informative, reliable, and practical content to our audience of analytical scientists.

    View Full Profile

Speaker

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...